Dipyridamole combined with immunoglobulin and aspirin in the treatment of Kawasaki disease in children: a meta-analysis.

Shi Y, Xu X, Yue Y, Zhao J, Yao K, Wu H

Open source

DOI
10.3389/fmed.2026.1837742
Published
2026
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1837742,
  title = {Dipyridamole combined with immunoglobulin and aspirin in the treatment of Kawasaki disease in children: a meta-analysis.},
  author = {Shi Y and Xu X and Yue Y and Zhao J and Yao K and Wu H},
  year = {2026},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2026.1837742},
  url = {https://doi.org/10.3389/fmed.2026.1837742}
}

RIS

TY  - JOUR
TI  - Dipyridamole combined with immunoglobulin and aspirin in the treatment of Kawasaki disease in children: a meta-analysis.
AU  - Shi Y
AU  - Xu X
AU  - Yue Y
AU  - Zhao J
AU  - Yao K
AU  - Wu H
PY  - 2026
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2026.1837742
UR  - https://doi.org/10.3389/fmed.2026.1837742
ER  - 

APA

Y, S., X, X., Y, Y., J, Z., K, Y., & H, W. (2026). Dipyridamole combined with immunoglobulin and aspirin in the treatment of Kawasaki disease in children: a meta-analysis.. Frontiers in medicine. https://doi.org/10.3389/fmed.2026.1837742

Source records